Manufacturer of Controlled Substances, Notice of Application, ISP Inc, 72410 [2012-29407]
Download as PDF
<![CDATA[
72410
Federal Register / Vol. 77, No. 234 / Wednesday, December 5, 2012 / Notices
The company plans to produce the
listed controlled substances in bulk to
be used in the manufacture of reagents
and drug calibrator controls which are
DEA exempt products.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than February 4, 2013.
Dated: November 27, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than February 4, 2013.
Dated: November 27, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–29407 Filed 12–4–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request;
Unemployment Insurance Title XII
Advances and Voluntary Repayment
Process
ACTION:
Notice.
[FR Doc. 2012–29411 Filed 12–4–12; 8:45 am]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances, Notice of Application, ISP
Inc
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on October 26, 2012,
ISP Inc., 238 South Main Street,
Assonet, Massachusetts 02702, made
application by renewal to the Drug
Enforcement Administration (DEA) as a
bulk manufacturer of the basic classes of
controlled substances:
Drug
Schedule
mstockstill on DSK4VPTVN1PROD with
2,5-Dimethoxyamphetamine
(7396).
Amphetamine (1100) ....................
Phenylacetone (8501) ..................
I
II
II
The company plans to manufacture
bulk API, for distribution to its
customers. The bulk 2,5Dimethoxyamphetamine will be used
for conversion into non-controlled
substances.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
VerDate Mar<15>2010
17:19 Dec 04, 2012
On November 30, 2012, the
Department of Labor (DOL) will submit
the Employment and Training
Administration (ETA) sponsored
information collection request (ICR)
titled, ‘‘Unemployment Insurance Title
XII Advances and Voluntary Repayment
Process,’’ to the Office of Management
and Budget (OMB) for review and
approval for continued use in
accordance with the Paperwork
Reduction Act (PRA) of 1995 (44 U.S.C.
3501 et seq.).
DATES: Submit comments on or before
December 31, 2012.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained from the RegInfo.gov
Web site, https://www.reginfo.gov/
public/do/PRAMain, on December 1,
2012, or by contacting Michel Smyth by
telephone at 202–693–4129 (this is not
a toll-free number) or sending an email
to DOL_PRA_PUBLIC@dol.gov.
Submit comments about this request
to the Office of Information and
Regulatory Affairs, Attn: OMB Desk
Officer for DOL–ETA, Office of
Management and Budget, Room 10235,
725 17th Street NW., Washington, DC
20503, Fax: 202–395–6881 (this is not a
toll-free number), email:
OIRA_submission@omb.eop.gov.
SUMMARY:
BILLING CODE 4410–09–P
Jkt 229001
FOR FURTHER INFORMATION CONTACT:
Contact Michel Smyth by telephone at
202–693–4129 (this is not a toll-free
number) or by email at
DOL_PRA_PUBLIC@dol.gov.
Authority: 44 U.S.C. 3507(a)(1)(D).
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
This
information collection allows a State to
maintain a process for the Governor to
request advances and repay advances
through correspondence with the
Secretary of Labor. This information
collection is subject to the PRA.
A Federal agency generally cannot
conduct or sponsor a collection of
information, and the public is generally
not required to respond to an
information collection, unless it is
approved by the OMB under the PRA
and displays a currently valid OMB
Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information if the
collection of information does not
display a valid Control Number. See 5
CFR 1320.5(a) and 1320.6. The DOL
obtains OMB approval for this
information collection under Control
Number 1205–0199. The current
approval is scheduled to expire on
November 30, 2012; however, it should
be noted that existing information
collection requirements submitted to the
OMB receive a month-to-month
extension while they undergo review.
For additional information, see the
related notice published in the Federal
Register on September 28, 2012 (77 FR
59669).
Interested parties are encouraged to
send comments to the OMB, Office of
Information and Regulatory Affairs at
the address shown in the ADDRESSES
section by December 31, 2012. In order
to help ensure appropriate
consideration, comments should
mention OMB Control Number 1205–
0199. The OMB is particularly
interested in comments that:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Agency: DOL–ETA.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\05DEN1.SGM
05DEN1
]]>Agencies
[Federal Register Volume 77, Number 234 (Wednesday, December 5, 2012)]
[Notices]
[Page 72410]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-29407]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Notice of Application, ISP
Inc
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on October 26, 2012, ISP Inc.,
238 South Main Street, Assonet, Massachusetts 02702, made application
by renewal to the Drug Enforcement Administration (DEA) as a bulk
manufacturer of the basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396)............ I
Amphetamine (1100)......................... II
Phenylacetone (8501)....................... II
------------------------------------------------------------------------
The company plans to manufacture bulk API, for distribution to its
customers. The bulk 2,5-Dimethoxyamphetamine will be used for
conversion into non-controlled substances.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than February 4, 2013.
Dated: November 27, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-29407 Filed 12-4-12; 8:45 am]
BILLING CODE 4410-09-P
